同位素稀释-超高效液相色谱-串联质谱技术分析人血浆中利奈唑胺的浓度

目的:建立超高效液相色谱-串联质谱法和同位素稀释内标法分析人血浆中利奈唑胺浓度的方法.方法:血浆样本经乙腈稀释沉淀蛋白进行前处理,以同位素利奈唑胺-d3为内标,采用Acquity UPLC(c)BEH-C18色谱柱(2.1 mm×50mm,1.7 μm)分离,流动相包括水(含0.1%甲酸,V/V)和乙腈(含0.1%甲酸,V/V),梯度洗脱,流速为0.3 ml/min.正离子检测模式下,采用多离子反应监测模式进行分析.结果:利奈唑胺浓度在0.078~10.000 μg/ml范围内线性关系良好,定量限为0.078 μg/ml;日内、日间RSD均<6%;提取回收率〉90%.结论:本方法操作简便、快速...

Full description

Saved in:
Bibliographic Details
Published in中国医院用药评价与分析 Vol. 17; no. 5; pp. 581 - 583
Main Author 王晓雪 车仙花 崔刚 张相林
Format Journal Article
LanguageChinese
Published 卫生部中日友好医院药学部,北京,100029%延边大学附属医院药学部,吉林 延吉,133000 2017
Subjects
Online AccessGet full text
ISSN1672-2124
DOI10.14009/j.issn.1672-2124.2017.05.002

Cover

Abstract 目的:建立超高效液相色谱-串联质谱法和同位素稀释内标法分析人血浆中利奈唑胺浓度的方法.方法:血浆样本经乙腈稀释沉淀蛋白进行前处理,以同位素利奈唑胺-d3为内标,采用Acquity UPLC(c)BEH-C18色谱柱(2.1 mm×50mm,1.7 μm)分离,流动相包括水(含0.1%甲酸,V/V)和乙腈(含0.1%甲酸,V/V),梯度洗脱,流速为0.3 ml/min.正离子检测模式下,采用多离子反应监测模式进行分析.结果:利奈唑胺浓度在0.078~10.000 μg/ml范围内线性关系良好,定量限为0.078 μg/ml;日内、日间RSD均<6%;提取回收率〉90%.结论:本方法操作简便、快速、准确、专属性强且稳定性良好,适用于人血浆中利奈唑胺浓度的分析,可用于临床治疗药物监测.
AbstractList R917; 目的:建立超高效液相色谱-串联质谱法和同位素稀释内标法分析人血浆中利奈唑胺浓度的方法.方法:血浆样本经乙腈稀释沉淀蛋白进行前处理,以同位素利奈唑胺-d3为内标,采用Acquity UPLC(c)BEH-C18色谱柱(2.1 mm×50 mm,1.7 μm)分离,流动相包括水(含0.1%甲酸,V/V)和乙腈(含0.1%甲酸,V/V),梯度洗脱,流速为0.3 ml/min.正离子检测模式下,采用多离子反应监测模式进行分析.结果:利奈唑胺浓度在0.078~10.000 μg/ml范围内线性关系良好,定量限为0.078 μg/ml;日内、日间RSD均<6%;提取回收率>90%.结论:本方法操作简便、快速、准确、专属性强且稳定性良好,适用于人血浆中利奈唑胺浓度的分析,可用于临床治疗药物监测.
目的:建立超高效液相色谱-串联质谱法和同位素稀释内标法分析人血浆中利奈唑胺浓度的方法.方法:血浆样本经乙腈稀释沉淀蛋白进行前处理,以同位素利奈唑胺-d3为内标,采用Acquity UPLC(c)BEH-C18色谱柱(2.1 mm×50mm,1.7 μm)分离,流动相包括水(含0.1%甲酸,V/V)和乙腈(含0.1%甲酸,V/V),梯度洗脱,流速为0.3 ml/min.正离子检测模式下,采用多离子反应监测模式进行分析.结果:利奈唑胺浓度在0.078~10.000 μg/ml范围内线性关系良好,定量限为0.078 μg/ml;日内、日间RSD均<6%;提取回收率〉90%.结论:本方法操作简便、快速、准确、专属性强且稳定性良好,适用于人血浆中利奈唑胺浓度的分析,可用于临床治疗药物监测.
Abstract_FL Objective:To establish a method for analysis of content of linezolid in human plasma by ultra performance liquid chromatography-tandem mass spectrometry with isotopes dilution.METHODS: Plasma samples were disposed by acetonitrile dilution protein deposition,isotope rina thiazole amine-d3 was set as internal control,and Acquity UPLC(c)BEH-C18 column(2.1 mm×50 mm,1.7 μm)was adopted,the mobile phase consisted of water(0.1%formic acid,V/V)and acetonitrile(0.1%formic acid,V/V)in gradient elution,at flow rate of 0.3 ml/min.Under positive ion detection mode,multiple ion reaction monitoring mode was adopted for analysis.RESULTS: The content of linezolid showed good linear relationship within 0.078 μg/ml-10.000 μg/ml,the limit of quantitation was 0.078 μg/ml.And RSD of intra-and inter-day precision <6%,the recovery >90%.CONCLUSIONS: This method is simple,rapid and accurate with strong specificity and good stability,which can be used for analysis of content of linezolid in human plasma and clinical therapeutic drug monitoring.
Author 王晓雪 车仙花 崔刚 张相林
AuthorAffiliation 卫生部中日友好医院药学部,北京100029 延边大学附属医院药学部,吉林延吉133000
AuthorAffiliation_xml – name: 卫生部中日友好医院药学部,北京,100029%延边大学附属医院药学部,吉林 延吉,133000
Author_FL WANG Xiaoxue
CUI Gang
CHE Xianhua
ZHANG Xianglin
Author_FL_xml – sequence: 1
  fullname: WANG Xiaoxue
– sequence: 2
  fullname: CHE Xianhua
– sequence: 3
  fullname: CUI Gang
– sequence: 4
  fullname: ZHANG Xianglin
Author_xml – sequence: 1
  fullname: 王晓雪 车仙花 崔刚 张相林
BookMark eNo9kM1Kw0AUhWdRwVr7EoI7E2cmk0yzlOIfFNx0HyZpp6ZoWhtE66qi1lgUKlYQFdGFUhFRS1tKwLfJX9_CSMWzuZzDuffCNwMSVsUqAjCPoIgIhOpiWTRt2xKRQrGAESYihoiKUBYhxAmQ_M-nQdq2TR1imUKMJZIEmt8-974vwv5j2G2MT1tCNDwZv90E104w7IV3o-isF31-Cd6oFx12on43NkGrEdx_-E4zeGh7rhs9NYJB0xu9-86r_-z4ncvoyA1vj4PBle--zIIpzrbsYvpvpkB-ZTmfXRNyG6vr2aWcYCgEC4QgyBVMZVXSEWeI6TrFkCqZAlEwKSgFbjBZllRdKhocUUgykBKmc0IyHGMkSymwMDm7xyzOrJJWruzWrPihdlCqx6qW63z_FwqUYyRxfW5SNzYrVmnHjBeqNXOb1epajIpgohIq_QD4Cohl
ClassificationCodes R917
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.14009/j.issn.1672-2124.2017.05.002
DatabaseName 维普_期刊
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Analysis on Content of Linezolid in Human Plasma by Ultra Performance Liquid Chromatography-tandem Mass Spectrometry with Isotopes Dilution
DocumentTitle_FL Analysis on Content of Linezolid in Human Plasma by Ultra Performance Liquid Chromatography-tandem Mass Spectrometry with Isotopes Dilution
EndPage 583
ExternalDocumentID zgyyyypjyfx201705002
672424947
GrantInformation_xml – fundername: 国家自然科学青年基金; 中日友好医院青年基金
  funderid: (81503175); (2014-3-QN-27)
GroupedDBID 2RA
92L
ALMA_UNASSIGNED_HOLDINGS
CDYEO
CQIGP
W91
~WA
2B.
4A8
92I
93N
ABDBF
ACUHS
EOJEC
OBODZ
PSX
TCJ
TUS
ID FETCH-LOGICAL-c642-4410f627593b1fa1abb720768d4624d6dfca5539b3ecf17048074abf448f22153
ISSN 1672-2124
IngestDate Thu May 29 04:11:27 EDT 2025
Wed Feb 14 10:00:21 EST 2024
IsPeerReviewed false
IsScholarly true
Issue 5
Keywords Linezolid
Ultra performance liquid chromatography-tandem mass spectrometry
Isotopes dilution
超高效液相色谱-串联质谱法
同位素稀释内标法
利奈唑胺
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c642-4410f627593b1fa1abb720768d4624d6dfca5539b3ecf17048074abf448f22153
Notes Objective:To establish a method for analysis of content of linezolid in human plasma by ultra performance liquid chromatography-tandem mass spectrometry with isotopes dilution.METHODS: Plasma samples were disposed by acetonitrile dilution protein deposition,isotope rina thiazole amine-d3 was set as internal control,and Acquity UPLC(c)BEH-C18 column(2.1 mm×50 mm,1.7 μm)was adopted,the mobile phase consisted of water(0.1%formic acid,V/V)and acetonitrile(0.1%formic acid,V/V)in gradient elution,at flow rate of 0.3 ml/min.Under positive ion detection mode,multiple ion reaction monitoring mode was adopted for analysis.RESULTS: The content of linezolid showed good linear relationship within 0.078 μg/ml-10.000 μg/ml,the limit of quantitation was 0.078 μg/ml.And RSD of intra-and inter-day precision 〈6%,the recovery 〉90%.CONCLUSIONS: This method is simple,rapid and accurate with strong specificity and good stability,which can be used for analysis of content of linezolid in human plasma and clinical therapeutic drug mon
PageCount 3
ParticipantIDs wanfang_journals_zgyyyypjyfx201705002
chongqing_primary_672424947
PublicationCentury 2000
PublicationDate 2017
PublicationDateYYYYMMDD 2017-01-01
PublicationDate_xml – year: 2017
  text: 2017
PublicationDecade 2010
PublicationTitle 中国医院用药评价与分析
PublicationTitleAlternate Evaluation and Analysis of Drug-use in Hospitals of China
PublicationTitle_FL Evaluation and Analysis of Drug-Use in Hospitals of China
PublicationYear 2017
Publisher 卫生部中日友好医院药学部,北京,100029%延边大学附属医院药学部,吉林 延吉,133000
Publisher_xml – name: 卫生部中日友好医院药学部,北京,100029%延边大学附属医院药学部,吉林 延吉,133000
SSID ssib025702234
ssib017477209
ssib001103637
ssib051368574
ssib000405437
ssib001215202
ssib036441963
ssib006563103
ssib057928707
Score 2.061093
Snippet 目的:建立超高效液相色谱-串联质谱法和同位素稀释内标法分析人血浆中利奈唑胺浓度的方法.方法:血浆样本经乙腈稀释沉淀蛋白进行前处理,以同位素利奈唑胺-d3为内标,采用Acquity UPLC(c)BEH-C18色谱柱(2.1 mm×50mm,1.7...
R917; 目的:建立超高效液相色谱-串联质谱法和同位素稀释内标法分析人血浆中利奈唑胺浓度的方法.方法:血浆样本经乙腈稀释沉淀蛋白进行前处理,以同位素利奈唑胺-d3为内标,采用Acquity UPLC(c)BEH-C18色谱柱(2.1 mm×50 mm,1.7...
SourceID wanfang
chongqing
SourceType Aggregation Database
Publisher
StartPage 581
SubjectTerms 利奈唑胺
同位素稀释内标法
超高效液相色谱-串联质谱法
Title 同位素稀释-超高效液相色谱-串联质谱技术分析人血浆中利奈唑胺的浓度
URI http://lib.cqvip.com/qk/86765X/201705/672424947.html
https://d.wanfangdata.com.cn/periodical/zgyyyypjyfx201705002
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NaxNBFF9KBfEiioq1Kj04J9m6OzuzM3OcTTYUQU8t1FPYTXZbPMSvFrSnil-1KFSsICqiB6Uiopa2lID_TZOm_4XvzW6SLS1SG8KyO_PmffzeJPNesvvGsi4x4UQ0Smq2TGrCZkrGdqSSxIbI3nFlXBcOxWeHr133xybY1Uk-OTDYLNy1NDsTj9bm9n2u5DBehTbwKz4l-x-e7TGFBjgH_8IRPAzHA_mYhJwoh8gSCRkJykSWSShIwIh28ERLvI8hVAQSfqltEkoS-ERybNIBUZKEPlGcSHMCXQHFYSoggURiqUwLjHJI4NpGiMybpEsUM30M5XSJkJHURiywLhFdQR1BgPRNS4j6Ih-Nbxil3Zw44IbGiNDlfJRWeKIzFTlKVK6R7pnhoCvIYvlw5SENtGu_GHLv4om2ZcxLJAgQCAVYZGZ3DQEUUW2JR2TOkDIQOR8Z7rWoO2uRDfTLwPQoo5FCmVr3SSRqoP2cL1ChSIDD7ZNwRBXhNYKU3tVTyr2buylTQRR_vckeUzWfNMOijN7OLFQVMx88Y2oPF-AhEGUkrhj1Dej7I9UDiONYNKTLkJZyeiVyH-sSNOJ_O1QRavgjlL4BISRB5l3AXeziBoKkMR7mkwoPowN-KFQPm8sFwd0-UMvzHMcpLMq-oDaEWGzXqi0K3068sATzbAugPJrjWaH1PYECLF3KRAooYbQnAe_1zEr5OrQfIfXuW52begCv2zcfpPepKURl6tgeoUK4fNA6ooNyUCkkS5AOFYJ_CLQ9v3iNW0oXiu9BZoWb_nWvXUj0Be0X1_Mwc1H9Ynncxb0j-skbFwpvWjC7SXXNOWqRrrFX_mUqFpaZvtWYugPhsnl6sZFGjalCoD1-wjqeZ8gjOvu6O2kNzE2fsqqtpRdbf15ur33aXpnfebZodzae7Hx_236z0N5Y3X6_2Xm-2vn1297aXO08XO6srcBFe3G-_eFna-Fp--PSVrPZ-TzfXn-6tfmjtfCt9WWhtfyq86i5_e5xe_11q_n1tDVeCcdLY3a-N4xd8xm1AQonxQLryovdNHKjOAashC_rzKes7tfTWsS5p2IvqaXgKCycwaI4ZUymFHD3zliDjVuN5Kw1IiitJYwpAYsV4_VUChr59cRNWRL5kB8NWcM9bKq3sxJAVQCRUaaYGLJIjlY1XxjuVfebJecOSDdsHcPz7Efe89bgzN3Z5AKkPTPxxXx-XYTE_8bEX_qxB7s
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E5%90%8C%E4%BD%8D%E7%B4%A0%E7%A8%80%E9%87%8A-%E8%B6%85%E9%AB%98%E6%95%88%E6%B6%B2%E7%9B%B8%E8%89%B2%E8%B0%B1-%E4%B8%B2%E8%81%94%E8%B4%A8%E8%B0%B1%E6%8A%80%E6%9C%AF%E5%88%86%E6%9E%90%E4%BA%BA%E8%A1%80%E6%B5%86%E4%B8%AD%E5%88%A9%E5%A5%88%E5%94%91%E8%83%BA%E7%9A%84%E6%B5%93%E5%BA%A6&rft.jtitle=%E4%B8%AD%E5%9B%BD%E5%8C%BB%E9%99%A2%E7%94%A8%E8%8D%AF%E8%AF%84%E4%BB%B7%E4%B8%8E%E5%88%86%E6%9E%90&rft.au=%E7%8E%8B%E6%99%93%E9%9B%AA&rft.au=%E8%BD%A6%E4%BB%99%E8%8A%B1&rft.au=%E5%B4%94%E5%88%9A&rft.au=%E5%BC%A0%E7%9B%B8%E6%9E%97&rft.date=2017&rft.pub=%E5%8D%AB%E7%94%9F%E9%83%A8%E4%B8%AD%E6%97%A5%E5%8F%8B%E5%A5%BD%E5%8C%BB%E9%99%A2%E8%8D%AF%E5%AD%A6%E9%83%A8%2C%E5%8C%97%E4%BA%AC%2C100029%25%E5%BB%B6%E8%BE%B9%E5%A4%A7%E5%AD%A6%E9%99%84%E5%B1%9E%E5%8C%BB%E9%99%A2%E8%8D%AF%E5%AD%A6%E9%83%A8%2C%E5%90%89%E6%9E%97+%E5%BB%B6%E5%90%89%2C133000&rft.issn=1672-2124&rft.volume=17&rft.issue=5&rft.spage=581&rft.epage=586&rft_id=info:doi/10.14009%2Fj.issn.1672-2124.2017.05.002&rft.externalDocID=zgyyyypjyfx201705002
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F86765X%2F86765X.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzgyyyypjyfx%2Fzgyyyypjyfx.jpg